RCOG, BMS, FSRH statement on HRT and contraceptive supply
The RCOG, BMS and FSRH have issued a press release regarding the HRT and contraceptive shortages.
The RCOG, BMS and FSRH have issued a press release regarding the HRT and contraceptive shortages.
A study published in The Lancet shows the risk of breast cancer with hormone replacement therapy (HRT) in relation to the type and timing of hormonal intake.
A meta-analysis published in the Lancet this week by the Collaborative Group on Hormonal Factors in Breast Cancer reported on the risk of breast cancer with HRT in relation to the type and timing of hormonal intake.
The Royal College of Obstetricians and Gynaecologists (RCOG), the British Menopause Society (BMS) and the Faculty of Sexual and Reproductive Health care (FSRH) are receiving multiple queries from women who are unable to access their hormone replacement therapy (HRT) products due to ongoing manufacturing and supply issues.
This documentary features Dr Heather Currie, Chair of the British Menopause Society (BMS). The British Menopause Society and the Royal College of Obstetricians and Gynaecologists (RCOG) have issued a statement ahead of the screening.
Results have been reported from a study of more than 4,200 women who received a coronary calcium scan at Cedars-Sinai Medical Center between 1998 and 2012. A coronary calcium scan is a CT scan that measures the amount of calcium in the heart's arteries.
Many women experience disturbed sleep as a menopausal symptom, which can have a significant effect on mood and energy levels and cause distress, and lead to increased risk of heart disease, diabetes and obesity.
The effect on breast cancer risk for women who carry the BRCA gene and the use of HRT after removal of ovaries for risk-reducing surgery.
The British Menopause Society and Royal College of Obstetricians and Gynaecologists issue a response to the findings that the effect of combined hormone replacement therapy (HRT) in increasing a woman’s risk of breast cancer is likely to have been underestimated by a number of previous studies.
The effect of combined hormone replacement therapy (HRT) in increasing a woman’s risk of breast cancer is likely to have been underestimated by a number of previous studies, according to a new prospective study published in the British Journal of Cancer.